Evidence map›Paper›PMID 40014145›Full record

ArticleLangenbeck's archives of surgery2025

The optimal cut-off value of postoperative day three C-reactive protein to predict for major complications in colorectal cancer patients.

Coco Smit, Maryska L Janssen-Heijnen, Frits van Osch, Jonas Rops, Anke H C Gielen, Maarten van Heinsbergen, Jarno Melenhorst, Joop L M Konsten

Abstract read
In one paragraph

Article in Langenbeck's archives of surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Coco SmitDepartment of Surgery, VieCuri Medical Centre, Venlo, The Netherlands. csmit@viecuri.nl.
Maryska L Janssen-HeijnenDepartment of Clinical Epidemiology, VieCuri Medical Centre, 5912 BL, Venlo, The Netherlands.
Frits van OschDepartment of Clinical Epidemiology, VieCuri Medical Centre, 5912 BL, Venlo, The Netherlands.
Jonas RopsMaastricht University, Faculty of Health, Medicine and Life Sciences, Maastricht, The Netherlands.
Anke H C GielenDepartment of Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands.
Maarten van HeinsbergenDepartment of Surgery, VieCuri Medical Centre, Venlo, The Netherlands.
Jarno MelenhorstGROW School for Oncology and Developmental Biology, Maastricht, The Netherlands.
Joop L M KonstenDepartment of Surgery, VieCuri Medical Centre, Venlo, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo identify an optimal postoperative day 3 (POD3) C-reactive protein (CRP) cut-off for predicting major complications in colorectal cancer (CRC) patients. Secondary objectives included identifying patient and surgical factors associated with POD3 CRP levels and assessing the accuracy of the cut-off across subgroups.

methodsA retrospective cohort study of 1536 CRC patients who underwent an oncological resection was conducted. The predictive accuracy of POD3 CRP for major complications was tested using Receiver Operating Characteristics curves. The CRP cut-off was tested across subgroups. Multivariable logistic regression analyses was performed to evaluate the predictive value of the POD3 CRP cut-off, while also determining whether patient and surgical characteristics independently predicted major complications.

resultsAn optimal cut-off of 114 mg/L was identified, with a sensitivity of 0.80 and specificity of 0.59 and an Area Under the Curve for POD3 CRP of 0.78. Sensitivity remained consistently high across all subgroups, whereas specificity exhibited variability, with a notable decrease observed in the subgroups; aged 66-69, obese, ASA III and open surgery. After adjusting for patient and surgery characteristics, a POD3 CRP level above 114 mg/L was associated with a significant 5.29-fold increase in the odds for developing major complications.

conclusionsA POD3 CRP cut-off of 114 mg/L is an effective predictor of major complications following CRC surgery, supporting safe early discharge. The cut-off remains a reliable predictor, even after adjusting for patient and surgery factors.

Indexed as

Colorectal NeoplasmsC-Reactive ProteinPostoperative ComplicationsAgedAged, 80 and overFemaleHumansMaleMiddle AgedPredictive Value of TestsRetrospective StudiesROC CurveC-Reactive ProteinColorectal cancerComplicationsCRPPostoperative monitoring

Identifiers

PMID40014145
PMCPMC11868158

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.